After years of moderate margins due to limited price hikes, drugmakers with heavy exposure to essential medicines are expected to register better growth.The government approved a 10.8% hike in the price of essential drugs regulated under the Drug Price Control Order, 2013, in line with the Wholesale Price Index effective from April 1. However, the actual impact on the numbers was seen from June 1 due to channel inventory. As a result...